Upper gastrointestinal disease in the elderly patient

Reviews in Clinical Gerontology

Volumn 15, Issue 3-4, 2005, Pages 175-185

  Johnston, R D ^a   Singhal, S ^b   Bowling, T E ^a,c  

^a NOTTINGHAM UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

^b SANDWELL GENERAL HOSPITAL   (United Kingdom)

^c QUEEN S MEDICAL CENTRE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; BARIUM; BOTULINUM TOXIN A; CISAPRIDE; CLOPIDOGREL; ESOMEPRAZOLE; FLUOROURACIL; FOLINIC ACID; NONSTEROID ANTIINFLAMMATORY AGENT; PLACEBO; PROTON PUMP INHIBITOR; ROFECOXIB;

AGED; BARIUM MEAL; BARRETT ESOPHAGUS; BLEEDING; CARDIOESOPHAGOMYOTOMY; DIAGNOSTIC ACCURACY; DRUG FATALITY; ENDOSCOPIC MUCOSAL RESECTION; ESOPHAGUS ACHALASIA; ESOPHAGUS CANCER; ESOPHAGUS DISEASE; ESOPHAGUS DYSMOTILITY; ESOPHAGUS MANOMETRY; ESOPHAGUS MOTILITY; ESOPHAGUS SCINTISCANNING; FALSE POSITIVE RESULT; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL DISEASE; GERIATRIC PATIENT; HEART ARRHYTHMIA; HEART FAILURE; HEART INFARCTION; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; LAPAROSCOPIC SURGERY; LIFESTYLE; PEPTIC ULCER; PRECANCER; REVIEW; RISK REDUCTION; STOMACH CANCER; STOMACH OBSTRUCTION; STROKE;

EID: 33845907949     PISSN: 09592598     EISSN: 14699036     Source Type: Journal    
DOI: 10.1017/S0959259806001857     Document Type: Review

References (68)

1. Destro, Maggi S, Crepaldi G. Epidemiology of gastrointestinal disorders in the elderly. In Pilotto A, Malfertheiner P, Holt P eds. Aging and the gastrointestinal tract. Basel: Karger Press, 2003, pp. 3-18.
2. Singhal S, Bowling TE. Upper gastrointestinal disease in elderly patients. Rev Clin Gerontol 2000; 10: 223-33.
3. Sonnenberg A, Massey BT, McCarty DJ et al. Epidemiology of hospitalization for achalasia in the United States. Dig Dis Sci 1993; 38: 233-44.
4. West RL, Hirsch DP, Bartelsman JF et al. Long-term results of pneumatic dilation in achalasia followed for more than 5 years. Am J Gastroenterol 2002; 97: 1346-51.
5. Dughera, Battaglia E, Maggio D et al. Botulinum toxin treatment of oesophageal achalasia in the old and oldest old: a 1-year follow-up study. Drugs Aging. 2005; 22: 779-83.
6. Katzka DA, Castell DO. Esophageal manometry and modern medicine. Dig Dis 1998; 16: 189-91.
7. Pandolfino JE, Howdne CW, Kahrilas PJ. Motility-modifying agents and management of disorders of gastrointestinal motility. Gastroenterology 2000; 118: S32-47.
8. Ruigomez A, Wallander MA, Johansson S et al. Natural history of gastroesophageal reflux disease diagnosed in UK general practice. Aliment Pharmacol Ther 2004; 20: 751-60.
9. Fass R, Pulliam G, Johnson C et al. Symptom severity and oesophageal chemosensitivity to acid in older and young patients with gastro-oesophageal reflux. Age Ageing 2000; 29: 125-30.
10. Devault KR, Castell DO. Updated guidelines for the diagnosis and treatment of gastroesophageal reflux disease. Am J Gastroenterol 2005; 100: 190-200.
11. Eshchar J, Pavlotzky MM, Cohen L et al. Gastrointestinal endoscopy in octogenarians. J Clin Gastroenterol. 1986; 8: 520-24.
12. Tew S, Jamieson GG, Pilowski I et al. The illness behaviour of patients with gastroesophageal reflux disease with and without endoscopic esophagitis. Dis Esophagus 1997; 10: 9-15.
13. Wiener GJ, Morgan TM, Copper JB et al. Ambulatory 24-hour esophageal pH monitoring. Reproducibility and variability of pH parameters. Dig Dis Sci 1998; 33: 1127-33.
14. Ott DJ, Wu WC, Gelfand DW. Reflux oesophagitis revisited: prospective analysis of radiological accuracy. Gastrointest Radiol 1981; 6: 1-7.
15. Meining A, Classen M. The role of diet and lifestyle measures in the pathogenesis and treatment of gastroesophageal reflux disease. Am J Gastroenterol 2000; 95: 2692-697.
16. Bais JE, Bartelsman JFWM, Binjer BJ et al. Laparoscopic or conventional Nissen fundoplication for gastro-oesophageal reflux disease: Randomized clinical trial. Lancet 2000; 355: 170-74.
17. Cameron AJ, Zinnmeister AR, Ballard DJ et al. Prevalence of columnar lined Barrett's oesophagus: comparison of population-based clinical and autopsy findings. Gastroenterology 1990; 99: 918-22.
18. Working party of the British Society of Gastroenterology. Guidelines for the diagnosis and management of Barrett's columnar-lined oesophagus. British Society of Gastroenterology Aug 2005.
19. Rudolph RE, Vaughan TL, Storer BE et al. Effect of segment length on risk for neoplastic progression in patients with Barrett's esophagus. Ann Intern Med 2000; 132: 612-20.
20. Schmidt HG, Riddell RH, Walther B et al. Dysplasia in Barrett's esophagus. J Cancer Res Clin Oncol 1985; 110: 145-52.
21. Falk GW, Rice TW, Goldblum JR et al. Jumbo biopsy forceps protocol still misses unsuspected cancer in Barrett's esophagus with high-grade dysplasia. Gastrointest Endosc 1999; 49: 170-76.
22. The World Health Report 1997. Geneva: World Health Organization, 1997.
23. Faivre J, Forman D, Esteve J et al. Survival of patients with oesophageal and gastric cancers in Europe. Eur J Cancer 1998; 34: 2167-75.
24. Bouvier AM, Launoy G, Lapage C et al. Trends in the management and survival of digestive tract cancers among patients aged over 80 years. Aliment Pharmacol Ther 2005; 22: 233-41.
25. Yang PC, Davis S. Incidence of cancer of the esophagus in the US by histology types. Cancer 1988; 61: 612-17.
26. Sabel MS, Smith JL, Nava HR et al. Esophageal resection for carcinoma in patients older than 70 years. Ann Surg Oncol 2002; 9: 210-14.
27. Alexiou C, Beggs D, Morgan WE et al. Surgery for esophageal cancer in elderly patients: the view from Nottingham. J Thorac Cardiovasc Surg 1998; 116: 545-53.
28. Thomas P, Doddoli C, Seitz JF et al. Esophageal cancer resection in the elderly. Eur J Card-Thor Surg 1996; 10: 941-46.
29. Kelsen DP, Ginsberg R, Pajak TF et al. Chemotherapy followed by surgery alone for localized esophageal cancer. N Eng J Med 1998; 339: 1979-84.
30. Medical Research Council Oesophageal Cancer Working Group. Surgical resection with or without preoperative chemotherapy in oesophageal cancer: a randomised controlled trial. Lancet 2002; 359: 1727-33.
31. Fiorica F, Di Bona D, Schepis F et al. Preoperative chemoradiotherapy for esophageal cancer: a systematic review and meta-analysis. Gut 2004; 53: 925-930.
32. Elphick DA, Smith BA, Bagshaw J et al. Self-expanding metal stents in the palliation of malignant dysphagia: Outcome analysis in 100 consecutive patients. Dis Esophagus 2005; 18: 93-95.
33. Pilotto A, Franceschi M, Valerio G et al. The effect of Helicobacter pylori infection on NSAID-related gastroduodenal damage in the elderly. Eur J Gastroenterol Hepatol 1997; 42: 586-91.
34. Lee M, Feldman M. The ageing stomach: implications for NSAID gastropathy. Gut 1997; 41: 575-76.
35. D. B. Hogan, N. R. Campbell, N. MacLeod et al. Prescription of nonsteroidal anti-inflammatory drugs for elderly people in Alberta. Can Med Assoc J 1994; 151: 315-22.
36. Pilotto A, Franceschi M, Leandro G et al. NSAID and aspirin use by the elderly in general practice. Effect on gastrointestinal symptoms and therapies. Drugs Aging 2003; 20: 701-10.
37. Pilotto A, Franceschi M, Leandro G et al. Proton-pump inhibitors reduce the risk of uncomplicated peptic ulcer in the elderly either acute or chronic users of aspirin/non-steroidal anti-inflammatory drugs. Aliment Pharmacol Ther 2004; 20: 1091-97.
38. Bresalier RS, Sandler RS, Quan H et al. Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial. N Eng J Med 2005; 352: 1092-102.
39. Fortun PJ, Hawkey CJ. Life after vioxx: the clinical implications. Hosp Med 2005; 66: 264-67.
40. Chan FKL, To KF, Wu JCY et al. Eradication of Helicobacter pylori and risk of peptic ulcers in patients starting long-term treatment with nonsteroidal anti-inflammatory drugs: a randomised trial. Lancet 2002; 359: 9-13.
41. Lingenfelser T, Ell C. Gastrointestinal bleeding in the elderly. Best Pract Res Clin Gastroenterol 2001; 15: 963-82.
42. Rockall TA, Logan RFA, Devlin HB et al. Incidence of and mortality from acute upper gastrointestinal haemorrhage in the United Kingdom. BMJ 1995; 311: 222-26.
43. Segal WN, Cello JP. Haemorrhage in the upper gastrointestinal tract in the older patient. Am J Gastroenterol 1997; 92: 42-46.
44. Solomon DH, Gurwitz JH. Toxicity of nonsteroidal anti-inflammatory drugs in the elderly: is advanced age a risk factor? Am J Medicine 1997; 102: 208-15.
45. Papatheodoridis GV, Papadelli D, Hadziyannis SJ et al. Effect of Helicobacter pylori Infection on the risk of upper gastrointestinal bleeding in users of non-steroidal anti-inflammatory drugs. Am J Med 2004; 116: 601-5.
46. Pahor M, Jack M, Salive ME et al. Physical activity and risk of severe gastrointestinal haemorrhage in older persons. JAMA 1994; 272: 595-99.
47. Rockall TA, Logan RFA, Devlin HB et al. Incidence of and mortality from acute upper gastrointestinal haemorrhage in the United Kingdom. BMJ 1995; 311: 222-26.
48. Rockall TA, Logan RFA, Devlin HB et al. Risk assessment after acute upper gastrointestinal haemorrhage. Gut 1996; 38: 316-21.
49. Zimmerman U, Siguencia J, Tsvand E et al. Predictors of mortality in patients admitted to hospital for acute upper gastrointestinal haemorrhage. Scand J Gastroenterol 1995; 30: 327-31.
50. Laine L, Peterson WL. Bleeding peptic ulcer. N Eng J Medicine 1994; 331: 717-27.
51. Chow LWC, Gertsch P, Poon RTP et al. Risk factors for re-bleeding and death from peptic ulcer in the very elderly. Br J Surgery 1998; 85: 121-24.
52. Courtney AE, Mitchell RMS, Rocke L et al. Proposed risk stratification in upper gastrointestinal haemorrhage: Is hospitalisation essential? Emerg Med J 2004; 21: 39-40.
53. Peter DJ, Dougherty JM. Evaluation of the patient with gastrointestinal bleeding: an evidencebased approach. Emerg Clin N Am 1999; 17: 239-61.
54. Lefkovitz Z, Capell MS, Kaplan M et al. Radiology in the diagnosis and the therapy of gastrointestinal bleeding. Gastroenterol Clin N Am 2000; 29: 489-512.
55. Egglin TKP, O'Moore PV, Feinstein AR et al. Complications of peripheral arteriography: a new system to identify patients at increased risk. J Vasc Surg 1995; 22: 787-94.
56. Lau JY et al. Effect of intravenous omeprazole on recurrent bleeding after endoscopic treatment of bleeding peptic ulcers. N Eng J Med 2000; 343: 310-16.
57. Kaviani MJ et al. Effect of oral omeprazole in reducing re-bleeding in bleeding peptic ulcers: a prospective, double-blind, randomised, clinical trial. Aliment Pharmacol Ther 2003; 17: 211-16.
58. Khuroo MS et al. A comparison of omeprazole and placebo for bleeding peptic ulcer. N Eng J Med 1997. 336: 1054-58.
59. Javid G et al. Omeprazole as adjuvant therapy to endoscopic combination injection sclerotherapy for treating bleeding peptic ulcer. Am J Med 2001; 111: 280-84.
60. Chan FKL, Ching JYL, Hung LCT et al. Clopidogrel versus aspirin and esomeprazole to prevent recurrent ulcer bleeding. New Eng J Med 2005; 352: 238-44.
61. Scottish Executive. The Scottish audit of gastric and oesophageal cancer 1997-1999. Edinburgh: Scottish Executive, 2002.
62. Inaba S, Hirayama H, Nagata C et al. Evaluation of a screening program on reduction of gastric cancer mortality in Japan: preliminary results from a cohort study. Prev Med 1999; 29: 102-09.
63. Matsukuma A, Furusawa M, Tomoda H et al. A clincopathological study of asymptomatic gastric cancer. Br J Cancer 1996; 74: 1647-50.
64. Ono H, Kondo H, Gotoda T et al. Endoscopic mucosal resection for treatment of early gastric cancer. Gut 2001; 48: 225-29.
65. Etoh T, Katai H, Fukugawa T et al. Treatment of early gastric cancer in the elderly patient: results of EMR and gastrectomy at a national referral centre in Japan. Gastrointest Endosc 2005; 62: 868-71.
66. Macdonald JS, Smalley SR, Benedetti J et al. Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N Eng J Med 2001; 345: 725-30.
67. Telford JJ, Carr-Locke DL, Baron TH et al. Palliation of patients with malignant gastric outlet obstruction with the enteral Wallstent: outcomes from a multi-centre study. Gastrointest Endosc 2004; 60: 916-20.
68. Baron TH. Surgical versus endoscopic palliation of malignant gastric outlet obstruction: big incision, little incision or no incision? Gastroenterol 2004; 127: 1268-69.